Health and Healthcare

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

307 Articles

Chris Lange | Dec 28, 2016 at 10:10 AM EST

Biotech Short Interest Sinks

The December 15 short interest data have been compared with the previous report, and short interest was down in most…

Lee Jackson | Dec 22, 2016 at 8:25 AM EST

RBC Likes Large Cap Biotech Leaders for 2017

In a new research report, the biotech team at RBC reveal their top picks for 2017, and while hardly pounding…

Lee Jackson | Dec 15, 2016 at 8:55 AM EST

Top Analysts Upgrades and Downgrades: AMD, Comerica, General Mills, Mastercard, Vertex Pharmaceuticals and More

Thursday’s top analyst upgrades, downgrades and initiations include Advanced Micro Devices, Comerica, General Mills, Mastercard and Vertex Pharmaceuticals.

Paul Ausick | Dec 13, 2016 at 4:04 PM EST

Alexion, Ophthotech Don’t Escape Tuesday’s 52-Week Low Club

December 13, 2016: Here are four stocks trading with relatively heavy volume among 41 equities making new 52-week lows in…

Jon C. Ogg | Dec 13, 2016 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Coca-Cola, IBM, Procter & Gamble, Viacom, SeaWorld, NovoCure and More

The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Amgen, Coca-Cola, IBM, Procter & Gamble, Viacom, SeaWorld…

Paul Ausick | Dec 12, 2016 at 4:04 PM EST

Ophthotech, Alexion Tumble into Monday’s 52-Week Low Club

December 12, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in…

Chris Lange | Dec 12, 2016 at 11:15 AM EST

Alexion Pharmaceuticals Shuffles the Deck With Recent Executive Changes

Alexion Pharmaceuticals saw its shares slide on Monday after the company reported a change in its executive team.

Chris Lange | Dec 12, 2016 at 9:10 AM EST

Biotech Short Interest Remains Mixed

The November 30 short interest data have been compared with the previous report, and short interest was mixed in the…

Chris Lange | Nov 28, 2016 at 7:35 AM EST

Short Sellers Grow More Aggressive on Major Biotechs

The November 15 short interest data have been compared with the previous report, and short interest increased in most of…

Lee Jackson | Nov 11, 2016 at 9:35 AM EST

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

With the Republicans now set to control both Congress and the White House, many on Wall Street feel that there…

Chris Lange | Nov 10, 2016 at 7:20 AM EST

Short Sellers Grow More Selective on Major Biotechs

Now that the U.S. presidential election is over and Hillary Clinton is out of the picture, major biotech companies can…

Jon C. Ogg | Nov 3, 2016 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Brocade, Facebook, First Solar, Fitbit, ONEOK Partners, Sunrun and More

The top analyst upgrades, downgrades and initiations seen on Thursday morning include Brocade Communications Systems, Facebook, First Solar, Fitbit, ONEOK…

Chris Lange | Oct 26, 2016 at 7:15 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The October 14 short interest data have been compared with the previous report, and short interest moves in these selected…

Chris Lange | Oct 12, 2016 at 7:10 AM EDT

Short Sellers Have Mixed Views on Major Biotechs

If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a…

Chris Lange | Sep 27, 2016 at 7:50 AM EDT

Short Sellers Increase Bets in Major Biotechs

The September 15 short interest data have been compared with the previous report, and short interest moves were upward across…

1 … 10 11 12 13 14 … 21

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

Biotech Short Interest Sinks

RBC Likes Large Cap Biotech Leaders for 2017

Top Analysts Upgrades and Downgrades: AMD, Comerica, General Mills, Mastercard, Vertex Pharmaceuticals and More

Alexion, Ophthotech Don’t Escape Tuesday’s 52-Week Low Club

Top Analyst Upgrades and Downgrades: Amgen, Coca-Cola, IBM, Procter & Gamble, Viacom, SeaWorld, NovoCure and More

Ophthotech, Alexion Tumble into Monday’s 52-Week Low Club

Alexion Pharmaceuticals Shuffles the Deck With Recent Executive Changes

Biotech Short Interest Remains Mixed

Short Sellers Grow More Aggressive on Major Biotechs

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

Short Sellers Grow More Selective on Major Biotechs

Top Analyst Upgrades and Downgrades: Brocade, Facebook, First Solar, Fitbit, ONEOK Partners, Sunrun and More

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Have Mixed Views on Major Biotechs

Short Sellers Increase Bets in Major Biotechs

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

Biotech Short Interest Sinks

RBC Likes Large Cap Biotech Leaders for 2017

Top Analysts Upgrades and Downgrades: AMD, Comerica, General Mills, Mastercard, Vertex Pharmaceuticals and More

Alexion, Ophthotech Don’t Escape Tuesday’s 52-Week Low Club

Top Analyst Upgrades and Downgrades: Amgen, Coca-Cola, IBM, Procter & Gamble, Viacom, SeaWorld, NovoCure and More

Ophthotech, Alexion Tumble into Monday’s 52-Week Low Club

Alexion Pharmaceuticals Shuffles the Deck With Recent Executive Changes

Biotech Short Interest Remains Mixed

Short Sellers Grow More Aggressive on Major Biotechs

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

Short Sellers Grow More Selective on Major Biotechs

Top Analyst Upgrades and Downgrades: Brocade, Facebook, First Solar, Fitbit, ONEOK Partners, Sunrun and More

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Have Mixed Views on Major Biotechs

Short Sellers Increase Bets in Major Biotechs

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do